Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-02-28 @ 11:21 AM
Study NCT ID:
NCT05392751
Status:
TERMINATED
Last Update Posted:
2024-10-15
First Post:
2022-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa
Sponsor:
Endogena Therapeutics, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
END-AU-CS101/201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None